Literature DB >> 15482158

Pseudomonal infection in cystic fibrosis: the battle continues.

Sarah Elkin1, Duncan Geddes.   

Abstract

Pseudomonas aeruginosa lung infection is the major cause of morbidity and mortality in patients with cystic fibrosis. Infection usually begins in childhood and is responsible for respiratory failure and death in most patients with cystic fibrosis. The organism triggers an exuberant chronic inflammatory reaction which damages the airways and leads to progressive loss of lung function. Over the last decade significant advances have been made in the understanding of the pathophysiology of cystic fibrosis airways disease. These should assist the development of new and better therapies to treat this pathogen. This review provides an overview of pseudomonal infection in cystic fibrosis, including mechanisms by which the bacteria may colonize the cystic fibrosis airway, persistence of pseudomonal infection and the biofilm mode of growth. Available treatments and possible novel approaches to therapy will be discussed.

Entities:  

Mesh:

Year:  2003        PMID: 15482158     DOI: 10.1586/14787210.1.4.609

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  16 in total

1.  The mechanism of heme transfer from the cytoplasmic heme binding protein PhuS to the delta-regioselective heme oxygenase of Pseudomonas aeruginosa.

Authors:  Mehul N Bhakta; Angela Wilks
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

2.  Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.

Authors:  Clement Mugabe; Majed Halwani; Ali O Azghani; Robert M Lafrenie; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Invasive Pulmonary Fungal Infections in Cystic Fibrosis.

Authors:  Carsten Schwarz; Claudia Brandt; Paul Whitaker; Sivagurunathan Sutharsan; Heino Skopnik; Silvia Gartner; Christina Smazny; Jobst F Röhmel
Journal:  Mycopathologia       Date:  2017-09-01       Impact factor: 2.574

4.  Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy.

Authors:  John W Lamppa; Karl E Griswold
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

5.  Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides.

Authors:  Yuxin Chen; Adriana I Vasil; Linda Rehaume; Colin T Mant; Jane L Burns; Michael L Vasil; Robert E W Hancock; Robert S Hodges
Journal:  Chem Biol Drug Des       Date:  2006-02       Impact factor: 2.817

6.  Javanicin, an antibacterial naphthaquinone from an endophytic fungus of neem, Chloridium sp.

Authors:  Ravindra N Kharwar; Vijay C Verma; Anuj Kumar; Surendra K Gond; James K Harper; Wilford M Hess; Emil Lobkovosky; Cong Ma; Yuhao Ren; Gary A Strobel
Journal:  Curr Microbiol       Date:  2008-11-19       Impact factor: 2.188

7.  The PqsR and RhlR transcriptional regulators determine the level of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa by producing two different pqsABCDE mRNA isoforms.

Authors:  Stephan Brouwer; Christian Pustelny; Christiane Ritter; Birgit Klinkert; Franz Narberhaus; Susanne Häussler
Journal:  J Bacteriol       Date:  2014-09-15       Impact factor: 3.490

8.  Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection.

Authors:  Charlotte C Teneback; Thomas C Scanlon; Matthew J Wargo; Jenna L Bement; Karl E Griswold; Laurie W Leclair
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

9.  Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa.

Authors:  Stephen M Bianchi; Lynne R Prince; Kathleen McPhillips; Lucy Allen; Helen M Marriott; Graham W Taylor; Paul G Hellewell; Ian Sabroe; David H Dockrell; Peter W Henson; Moira K B Whyte
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

10.  Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.

Authors:  Audrey Bellemare; Nathalie Vernoux; Sébastien Morin; Stéphane M Gagné; Yves Bourbonnais
Journal:  BMC Microbiol       Date:  2010-10-08       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.